XML 21 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenue, net $ 23,612 $ 27,461
Cost of product revenue (excluding $6,235 and $772 in intangible asset amortization for the years ended December 31, 2024, and 2023, respectively, shown separately below) 7,417 2,173
Intangible asset amortization 6,235 772
Operating expenses:    
Research and development 42,095 39,806
Selling, general and administrative 54,868 34,314
Total operating expenses 96,963 74,120
Loss from operations (87,003) (49,604)
Other (expense) income:    
Interest expense (7,351) (1,501)
Fair value adjustment related to warrant and CVR liability 2,057 (98)
Fair value adjustment related to investments (18) 613
Interest and other income, net 2,175 4,541
Total other (expense) income (3,137) 3,555
Loss before income taxes (90,140) (46,049)
Income tax expense (15,371) 0
Net loss $ (105,511) $ (46,049)
Basic and diluted net loss per share of common stock:    
Net loss (in dollars per share) $ (2.28) $ (1.3)
Weighted average number of shares of common stock outstanding:    
Basic and diluted (in shares) 46,251,239 35,452,460